Prescribing clinicians

Invisible Disability: Cognitive Impairment In Substance Use Disorder

Presenter: Chrystal Fullen, Psy.D Substance use can affect cognition during intoxication, withdrawal, and long-term recovery, sometimes resulting in persistent cognitive impairment. This presentation reviews the cognitive effects of commonly used substances, mild vs major neurocognitive disorder, and neurological risks such as hypoxic brain injury, TBI,  stroke, and dementia. Participants will also learn practical approaches to […]

Invisible Disability: Cognitive Impairment In Substance Use Disorder Read More »

Guidelines for the Use of Human Milk in the Context of Substance Use Disorder

Please join Alane O’Connor, DNP and Kara Kaikini, MS, IBCLC, as they discuss the Guidelines for the Use of Human Milk in the Context of Substance Use Disorder Description: Breastfeeding initiation rates are significantly lower in pregnant women with substance use disorder (SUD). While prenatal intention to breastfeed is often high in women receiving SUD

Guidelines for the Use of Human Milk in the Context of Substance Use Disorder Read More »

PMP Series - Rx pad with meds and outline of the state of maine

PMP Series | Overdose Reversal Medications

Please join Nicolette Centanni, PharmD, BCPS, BCGP, BCPP, as she explores overdose reversal medications in this PMP Series. Learning Objectives: 1. Identify what overdose reversal medications are currently available 2. Describe how overdose reversal medications counteract the effects of opioids in the body 3. Discuss differences and similarities in overdose reversal medications and common scenarios

PMP Series | Overdose Reversal Medications Read More »

The Modern Illicit Drug Environment, Adulterants, Trends, and Threats

In this presentation Robert Lawlor Jr. MS-ADPP, MS, BSCJ provides an overview of the current illicit drug environment, with a focus on emerging trends, common adulterants, and the growing risks they create for both public health and public safety. Participants will gain a clearer understanding of how today’s drug supply is changing and why awareness

The Modern Illicit Drug Environment, Adulterants, Trends, and Threats Read More »

Infectious Disease Syndemic and Substance Use in Maine: From Surveillance to Action

Join Courtney Pladsen, DNP, FNP, RN, and Kate Russell Woodworth, MD, MPH, FAAP, as they explore the intersection of infectious disease and substance use in Maine and discuss strategies to improve screening, prevention, and care. Learning Objectives: Recognize current infectious disease trends and common co-infections (HIV, HCV, HBV, STIs) among patients with substance use disorder

Infectious Disease Syndemic and Substance Use in Maine: From Surveillance to Action Read More »

Building a Culture of Safety: Trauma-Informed Systems, Stigma Reduction, and Workforce Sustainability

This interactive lecture invites healthcare professionals to explore how stigma shows up in clinical language, policies, and unconscious bias—and how trauma-informed care and battling compassion fatigue can transform patient experiences. Participants will learn practical tools to increase patients’ sense of safety, choice, collaboration, and empowerment across care settings. Learning Objectives: Analyze how stigma manifests in

Building a Culture of Safety: Trauma-Informed Systems, Stigma Reduction, and Workforce Sustainability Read More »

Breaking Barriers to Recovery: Making Extended-Release Buprenorphine Affordable & Accessible

This presentation reviews the logistics of initiating Extended-Release Buprenorphine (XRB) services in your office while maintaining regulatory compliance. We will explore the different procurement pathways and how each option impacts both practice budgets and patient out-of-pocket costs. Additionally, we will examine available financial assistance resources and strategies to help provide XRB at little to no

Breaking Barriers to Recovery: Making Extended-Release Buprenorphine Affordable & Accessible Read More »

Behavioral and Psychological Symptoms of Dementia

This talk will review the symptoms and behaviors often termed behavioral and psychological symptoms of dementia (BPSD). Literature that lead to national guidelines will be evaluated and explained for a better understanding of the pathophysiology and treatment of these often distressing symptoms. The place in therapy of antipsychotics and other medical and non-medical interventions in

Behavioral and Psychological Symptoms of Dementia Read More »